Natalja Strelkowa | Senior Principal Scientist, Translational Medicine and Clinical Pharmacology
BI Pharma GmBH & Co. KG

Natalja Strelkowa is a seasoned Drug Development Professional in Data Science, Preclinical Development and Clinical Pharmacology at Boehringer Ingelheim. With a strong background in pharmaceutical research and development, Natalja is dedicated to advancing precision medicine and healthcare through innovative data-driven approaches. Her expertise lies in leveraging data analytics to drive insights that optimize drug development processes and improve patient outcomes. Natalja's work focuses on bridging the gap between preclinical research and clinical trials, ensuring the successful translation of scientific discoveries into tangible benefits for patients. With a passion for cutting-edge technologies and a commitment to excellence, Natalja is at the forefront of driving innovation in the pharmaceutical industry. At BioTechX Europe 2025, Natalja will share her insights on the intersection of data and precision medicine, highlighting the transformative potential of these technologies in shaping the future of healthcare.